Kiadis Pharma

03.11.2020 • News

Sanofi Strengthens Immunology with Kiadis Buy

French pharma Sanofi is boosting once again its immunology portfolio with an agreement to buy Dutch biotech Kiadis for €308 million.

Top-Feature

Brenntag SE

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Free Expert Insights

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Kiadis Pharma

Sanofi Strengthens Immunology with Kiadis Buy

Top-Feature

Brenntag Downsizes Management Board, Retains Both Divisions

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

20 Years of CHEManager International

A successful concept on course for expansion — maintenance Munich 2025

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Free Expert Insights

Dual‑Targeting Breakthroughs

Newsletter & e-edition